GERN·374163103·US·equity·Healthcare - Biotechnology-13D/G
GERN (GERON CORP) is held by 125 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($95M), BlackRock, Inc. ($70.5M), STATE STREET CORP ($45.4M). Net institutional sentiment: Mixed.
See how GERN's score breaks down across 4 SEC sources
Showing 1-20 of 143
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer